U.S. biotech firm Moderna says vaccine 94.5% effective for COVID-19

Biotechnology company Moderna Inc. said Monday that its experimental vaccine was 94.5 percent effective in preventing COVID-19, making it the second U.S. firm to show promising results in developing a vaccine against the coronavirus pandemic.The Massachusetts-based company said it plans to apply for emergency use authorization in the United States in the coming weeks and also submit authorization applications to global regulatory agencies.The company has an agreement with the Japanese government to supply the Asian country with enough vaccine doses for 25 million people starting in the first h…

Read More

HEDGE accordingly